GIOSTAR Mexico offers NK cell therapy for rectal cancer at its clinic in Los Algodones, Baja California, Mexico. The COFEPRIS-authorized clinic has an ISO Class 5/7 laboratory, and its protocols were developed by Dr. Anand Srivastava, who has over 20 years of cancer research experience.
Evaluation before NK cell therapy
The team reviews oncology records remotely, then assesses the patient at the clinic. Evaluation may include clinical, genetic, and functional tests, plus laboratory exams before the first application.
- Remote record review: The team reviews health history and oncology records to assess treatment eligibility.
- On-site assessment: A medical consultation and nutritional assessment take place at the clinic.
- Laboratory exams: Tests are performed the day before the first application.
NK cell therapy for stage 1–2 cancer
This immune cell therapy is offered for early-stage cancer and complements conventional oncology care. Patients with stage 3 or stage 4 cancer are not eligible for this treatment. The protocol uses the patient’s natural killer (NK) cells, which are collected through leukapheresis, expanded in a laboratory, and activated before intravenous infusion. Treatment is given under medical supervision, with follow-up monitoring after the patient returns home.
- NK cell therapy: The process includes cell collection, laboratory expansion and activation, then intravenous infusion.
- NK cell therapy during remission: This option supports immune surveillance and recovery after chemotherapy or radiation.
Potential aims include supporting immune function, reducing inflammation, and addressing tumor activity. Individual responses can vary, and the clinic describes this therapy as complementary to conventional cancer care.
Patients can request a consultation through Bookimed to ask whether the clinic’s NK cell therapy may fit their case.
The clinic is not accepting new requests
Average answering time – 5 minutes
